Droits & Societe
Five new medicines recommended for approval by EMA
The European Medicines Agency (EMA)'s human medicines committee (CHMP) recommended five new medicines for approval at its April 2026 meeting. This includes Redemplo for familial chylomicronaemia syndrome, a rare genetic disorder. These recommendations mean more treatment options for various conditions are moving closer to becoming available for patients across the EU.
EMA recommends five new medicines, expanding treatment options for EU citizens.